TRLS — Trellus Health Income Statement
0.000.00%
Last trade - 00:00- £2.66m
- -£3.38m
- $0.02m
- 10
- 26
- 76
- 26
Annual income statement for Trellus Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.025 | 0.018 | 0.019 |
| Cost of Revenue | ||||
| Gross Profit | — | 0.025 | 0.018 | 0.019 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 0.762 | 5.93 | 8.83 | 6.82 |
| Operating Profit | -0.762 | -5.9 | -8.81 | -6.8 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.762 | -5.9 | -8.81 | -6.34 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.762 | -5.9 | -8.81 | -6.34 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.762 | -5.9 | -8.81 | -6.34 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.762 | -5.9 | -8.81 | -6.34 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.005 | -0.045 | -0.054 | -0.038 |
| Dividends per Share |